Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2010

01.10.2010 | General Gynecology

Decreased expression of Beclin 1 in eutopic endometrium of women with adenomyosis

verfasst von: Yuefang Ren, Lin Mu, Xiaoyan Ding, Wei Zheng

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Researchers have launched a new area of febrile investigations on the autophagy-related gene Beclin 1. Our aim is to investigate whether Beclin 1 expression is altered in eutopic endometrium of women with adenomyosis and its association with clinical characteristics.

Methods

We collected tissue samples from the eutopic endometria of 30 women with adenomyosis and 32 healthy women undergoing surgery for benign indications. We cultured the stromal cells of the eutopic endometria. Beclin 1 expression of the cultured stromal cells and tissues was assessed by reverse transcription polymerase chain reaction and western blot analysis.

Results

Beclin 1 messenger RNA (mRNA) expression in cultured stromal cells of eutopic endometria and endometrial tissues of women with adenomyosis was significantly lower than that of controls (P < 0.05). Beclin 1 protein expression in cultured stromal cells of eutopic endometria and endometrial tissues of adenomyosis was also significantly lower compared with that of controls (P < 0.01). Beclin 1 protein expression in eutopic endometrial tissues was negatively correlated with serum CA125 (r = −0.307, P = 0.015), and pelvic pain (r = −0.542, P = 0.000).

Conclusions

The study revealed Beclin 1 mRNA and protein expression were significantly decreased in eutopic endometria of women with adenomyosis. Moreover, Beclin 1 was negatively correlated with serum CA125 and pelvic pain. Beclin 1 might contribute to the pathogenesis and progression of endometriosis. Further research on autophagy of adenomyosis is required.
Literatur
1.
Zurück zum Zitat Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG (1997) Risk factors for adenomyosis. Hum Reprod 12:1275–1279CrossRefPubMed Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG (1997) Risk factors for adenomyosis. Hum Reprod 12:1275–1279CrossRefPubMed
2.
Zurück zum Zitat Devlieger R, D’Hooghe T, Timmerman D (2003) Uterine adenomyosis in the infertility clinic. Hum Reprod Update 9:139–147CrossRefPubMed Devlieger R, D’Hooghe T, Timmerman D (2003) Uterine adenomyosis in the infertility clinic. Hum Reprod Update 9:139–147CrossRefPubMed
3.
Zurück zum Zitat Edinger AL, Thompson CB (2004) Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16:663–669CrossRefPubMed Edinger AL, Thompson CB (2004) Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16:663–669CrossRefPubMed
4.
Zurück zum Zitat Tsujimoto Y, Shimizu S (2005) Another way to die: autophagic programmed cell death. Cell Death Differ 12(Suppl 2):1528–1534CrossRefPubMed Tsujimoto Y, Shimizu S (2005) Another way to die: autophagic programmed cell death. Cell Death Differ 12(Suppl 2):1528–1534CrossRefPubMed
5.
Zurück zum Zitat Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E et al (1999) Cloning and genomic structure of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59:59–65CrossRefPubMed Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E et al (1999) Cloning and genomic structure of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59:59–65CrossRefPubMed
6.
Zurück zum Zitat Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I et al (2007) Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 30:429–436PubMed Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I et al (2007) Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 30:429–436PubMed
7.
Zurück zum Zitat Wang ZH, Xu L, Duan ZL, Zeng LQ, Yan NH, Peng ZL (2007) Beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells. Gynecol Oncol 107:107–113CrossRefPubMed Wang ZH, Xu L, Duan ZL, Zeng LQ, Yan NH, Peng ZL (2007) Beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells. Gynecol Oncol 107:107–113CrossRefPubMed
8.
Zurück zum Zitat Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H et al (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402:672–676CrossRefPubMed Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H et al (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402:672–676CrossRefPubMed
9.
Zurück zum Zitat Tsai SJ, Wu MH, Lin CC, Sun HS, Chen SM (2001) Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab 86:5765–5773CrossRefPubMed Tsai SJ, Wu MH, Lin CC, Sun HS, Chen SM (2001) Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab 86:5765–5773CrossRefPubMed
10.
Zurück zum Zitat Wing LY, Chuang PC, Wu MH, Chen HM, Tsai SJ (2003) Expression and mitogenic effect of fibroblast growth factor-9 in human endometriotic implant is regulated by aberrant production of estrogen. J Clin Endocrinol Metab 88:5547–5554CrossRefPubMed Wing LY, Chuang PC, Wu MH, Chen HM, Tsai SJ (2003) Expression and mitogenic effect of fibroblast growth factor-9 in human endometriotic implant is regulated by aberrant production of estrogen. J Clin Endocrinol Metab 88:5547–5554CrossRefPubMed
11.
Zurück zum Zitat Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A et al (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112:1809–1820PubMed Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A et al (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112:1809–1820PubMed
12.
Zurück zum Zitat Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K et al (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21:1367–1381CrossRefPubMed Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K et al (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21:1367–1381CrossRefPubMed
13.
Zurück zum Zitat Ota H, Igarashi S, Hatazawa J, Tanaka T (1998) Is adenomyosis an immune disease? Hum Reprod Update 4:360–367CrossRefPubMed Ota H, Igarashi S, Hatazawa J, Tanaka T (1998) Is adenomyosis an immune disease? Hum Reprod Update 4:360–367CrossRefPubMed
14.
Zurück zum Zitat Wang F, Wen Z, Li H, Yang Z, Zhao X, Yao X (2008) Human leukocyte antigen-G is expressed by the eutopic and ectopic endometrium of adenomyosis. Fertil Steril 90:1599–1604CrossRefPubMed Wang F, Wen Z, Li H, Yang Z, Zhao X, Yao X (2008) Human leukocyte antigen-G is expressed by the eutopic and ectopic endometrium of adenomyosis. Fertil Steril 90:1599–1604CrossRefPubMed
15.
Zurück zum Zitat Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T et al (2005) Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307:593–596CrossRefPubMed Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T et al (2005) Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307:593–596CrossRefPubMed
16.
Zurück zum Zitat Furuya N, Yu J, Byfield M, Pattingre S, Levine B (2005) The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 1:46–52CrossRefPubMed Furuya N, Yu J, Byfield M, Pattingre S, Levine B (2005) The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 1:46–52CrossRefPubMed
17.
Zurück zum Zitat Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH et al (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8:688–699CrossRefPubMed Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH et al (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8:688–699CrossRefPubMed
18.
Zurück zum Zitat Oberstein A, Jeffrey PD, Shi Y (2007) Crystal structure of the Bcl-XLBeclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 282:13123–13132CrossRefPubMed Oberstein A, Jeffrey PD, Shi Y (2007) Crystal structure of the Bcl-XLBeclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 282:13123–13132CrossRefPubMed
19.
Zurück zum Zitat Sun Y, Zhang J, Peng ZL (2009) Beclin1 induces autophagy and its potential contributions to sensitizes SiHa cells to carboplatin therapy. Int J Gynecol Cancer 19:772–776PubMed Sun Y, Zhang J, Peng ZL (2009) Beclin1 induces autophagy and its potential contributions to sensitizes SiHa cells to carboplatin therapy. Int J Gynecol Cancer 19:772–776PubMed
20.
Zurück zum Zitat Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN et al (2007) Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128:931–946CrossRefPubMed Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN et al (2007) Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128:931–946CrossRefPubMed
21.
Zurück zum Zitat Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y et al (2008) Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 4:669–679PubMed Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y et al (2008) Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 4:669–679PubMed
22.
Zurück zum Zitat Kim DK, Yang JS, Maiti K, Hwang JI, Kim K, Seen D et al (2009) A gonadotropin-releasing hormone-II antagonist induces autophagy of prostate cancer cells. Cancer Res 69:923–931CrossRefPubMed Kim DK, Yang JS, Maiti K, Hwang JI, Kim K, Seen D et al (2009) A gonadotropin-releasing hormone-II antagonist induces autophagy of prostate cancer cells. Cancer Res 69:923–931CrossRefPubMed
23.
Zurück zum Zitat Gründker C, Günthert AR, Millar RP, Emons G (2002) Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 87:1427–1430CrossRefPubMed Gründker C, Günthert AR, Millar RP, Emons G (2002) Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 87:1427–1430CrossRefPubMed
24.
Zurück zum Zitat John S, Nayvelt I, Hsu HC, Yang P, Liu W, Das GM et al (2008) Regulation of estrogenic effects by beclin 1 in breast cancer cells. Cancer Res 68:7855–7863CrossRefPubMed John S, Nayvelt I, Hsu HC, Yang P, Liu W, Das GM et al (2008) Regulation of estrogenic effects by beclin 1 in breast cancer cells. Cancer Res 68:7855–7863CrossRefPubMed
Metadaten
Titel
Decreased expression of Beclin 1 in eutopic endometrium of women with adenomyosis
verfasst von
Yuefang Ren
Lin Mu
Xiaoyan Ding
Wei Zheng
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2010
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-009-1280-0

Weitere Artikel der Ausgabe 4/2010

Archives of Gynecology and Obstetrics 4/2010 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.